FDA REQUESTS WITHDRAWAL OF WEIGHT-LOSS DRUG FROM MARKET

被引：1
|
作者：
Aschenbrenner, Diane S. [1 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA
来源：
AMERICAN JOURNAL OF NURSING | 2020年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：22 / 23
页数：3
相关论文
共 50 条
  • [1] FDA requests withdrawal of lorcaserin from US market
    [J]. Reactions Weekly, 2020, 1792 (1) : 1 - 1
  • [2] There's one less weight-loss drug on the market
    Hynes, Marijane
    [J]. JOURNAL OF FAMILY PRACTICE, 2020, 69 (03): : E23 - E23
  • [3] FDA requests market withdrawal of all ranitidine products
    [J]. Reactions Weekly, 2020, 1799 (1) : 4 - 4
  • [4] NEW WEIGHT-LOSS DRUG APPROVED
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2012, 112 (10) : 48 - 49
  • [5] RARE REPORTS OF LIVER DAMAGE FROM WEIGHT-LOSS DRUG
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2010, 110 (10) : 28 - 28
  • [6] EFFECT OF FEED AND WATER WITHDRAWAL FROM BROILERS ON WEIGHT-LOSS AND CARCASS YIELDS
    MURPHY, BD
    GOODWIN, TL
    [J]. ARKANSAS FARM RESEARCH, 1978, 27 (05): : 9 - 9
  • [7] Should the FDA approval process for weight-loss drugs be modified?
    Hendricks, Ed J.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (21) : 2094 - 2095
  • [8] Efficacy and safety of the weight-loss drug rimonabant
    Despres, Jean-Pierre
    Van Gaal, Luc
    Pi-Sunyer, Xavier
    Scheen, Andre
    [J]. LANCET, 2008, 371 (9612): : 555 - 555
  • [9] THE WEIGHT-LOSS PROFILE - A BIOPSYCHOSOCIAL APPROACH TO WEIGHT-LOSS
    FEUERSTEIN, M
    PAPCIAK, A
    SHAPIRO, S
    TANNENBAUM, S
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1989, 19 (02): : 181 - 192
  • [10] PRECLINICAL PHARMACOLOGY OF FLUOXETINE, A SEROTONERGIC DRUG FOR WEIGHT-LOSS
    YEN, TT
    FULLER, RW
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (01): : 177 - 180
12345